A protein involved in cell metabolism, called PKM2, was found to be central to switching ‘on’ immune cells that play critical roles in inflammatory and autoimmune diseases such as multiple sclerosis (MS), an early study reports. Blocking the activity of PKM2 (pyruvate kinase M2) eased MS-like symptoms…
news-comment
Recommended Posts
- AAN 2026: Ocrevus treatment slows disability in advanced PPMS
- I learn a new lesson about not feeling guilty when good things come my way
- Guest Voice: I’m riding 100 miles a month for the MS community
- AAN 2026: Fenebrutinib outperforms Aubagio for treating relapsing MS
- Scientists studying yak genetics discover myelin repair mechanism